Evidence map›Paper›PMID 28357414›Full record

ArticlemSphere

A Novel

Katie Cater, Vidya Sree Dandu, S M Nayeemul Bari, Kim Lackey, Gabriel F K Everett, Asma Hatoum-Aslan

Open access · goldAbstract read
In one paragraph

Article in mSphere. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Vancomycin and phage COP-80B combination therapy for Staphylococcus epidermidis periprosthetic joint infections: a preclinical mouse study.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  3. Article
  4. Article
  5. Complete genome sequences ofMicrobiology resource announcements · 2026
    Article
  6. Article
  7. Article
  8. Viral Genome Delivery Across Bacterial Cell Surfaces.Annual review of microbiology · 2024
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Genetic Engineering of Therapeutic Phages Using Type III CRISPR-Cas Systems.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  14. Article
  15. Isolation andFrontiers in cellular and infection microbiology · 2023
    Article
  16. Article
  17. Structure and host specificity ofScience advances · 2022
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Katie CaterDepartment of Biological Sciences, The University of Alabama, Tuscaloosa, Alabama, USA.
Vidya Sree DanduDepartment of Biological Sciences, The University of Alabama, Tuscaloosa, Alabama, USA.
S M Nayeemul BariDepartment of Biological Sciences, The University of Alabama, Tuscaloosa, Alabama, USA.
Kim LackeyDepartment of Biological Sciences, The University of Alabama, Tuscaloosa, Alabama, USA.
Gabriel F K EverettCenter for Phage Technology, Texas A&M University and Texas A&M AgriLife, College Station, Texas, USA.
Asma Hatoum-AslanDepartment of Biological Sciences, The University of Alabama, Tuscaloosa, Alabama, USA.
University of Alabama · US

Funding

Understanding CRISPR-cas regulation and its impact in staphylococciK22AI113106 · NIAID · UNIVERSITY OF ALABAMA IN TUSCALOOSA · PI HATOUM, ASMA · 2015 to 2016
$267k
NIAID NIH HHS K22 AI113106
6 · The paper itself

Abstract

Drug-resistant staphylococci, particularly

Indexed as

antimicrobial agentsbacteriophage lysisbacteriophagesbacteriophage therapyStaphylococcus

Identifiers

PMID28357414
PMCPMC5362749
OpenAlexW2598701129

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.